WASHINGTON, D.C — The Federal Trade Commission (FTC) has announced the distribution of over $536,000 in refunds to individuals who purchased Sobrenix, a dietary supplement sold by the company Rejuvica. This action follows allegations that the company falsely marketed Sobrenix as a solution to reduce and eliminate alcohol cravings and consumption.
According to a complaint filed by the FTC in July 2023, Rejuvica, along with its owners Kyle Armstrong and Kyle Dilger, engaged in multiple deceptive practices to promote Sobrenix. These practices included making unfounded claims about the supplement’s efficacy and employing paid endorsers to disseminate these assertions through ads that appeared misleadingly authoritative. Moreover, the FTC discovered that the defendants operated fraudulent review sites designed to seem independent, further misleading consumers about the reliability and effectiveness of Sobrenix.
The FTC’s findings highlighted the lack of scientific evidence supporting the claims made by Rejuvica regarding Sobrenix’s ability to curb alcohol cravings. The deceptive marketing strategies employed by the company misled consumers into believing in the product’s unverified benefits, prompting regulatory intervention.
To address the harm caused by these misleading practices, the FTC is directing refunds to 56,686 consumers who purchased Sobrenix. These refunds are being issued in the form of checks, and recipients are advised to cash them within 90 days of the issue date. This refund initiative reflects the FTC’s efforts to ensure that consumers are compensated for purchases made under false pretenses.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.